Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1981 Oct;40(5):480–488. doi: 10.1136/ard.40.5.480

Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.

J S Dixon, M E Pickup, H A Bird, M R Lee, V Wright, W W Downie
PMCID: PMC1000785  PMID: 6796009

Abstract

Biochemical and clinical changes have been monitored in 30 patients with rheumatoid arthritis treated with either hydroxychloroquine or sodium aurothiomalate over a period of 6 months. Acute-phase reactants improved in both treatment groups, while serum sulphydryl and serum histidine improved only in the gold-treated patients. Correlation matrices were constructed from mean clinical and biochemical data at successive clinic visits. Correlations obtained with gold were more frequent and of a higher level of significance than those obtained with hydroxychloroquine at the doses we studied. This lends support to the use of correlation matrices as a screening test for potential long-term antirheumatoid activity of drugs in man.

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird H. A., Dixon J. S., Pickup M. E., Lee M. R., Wright V. A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis. Ann Rheum Dis. 1980 Jun;39(3):281–284. doi: 10.1136/ard.39.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dixon J. S., Pickup M. E., Lowe J. R., Hallett C., Lee M. R., Wright V. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis. 1980 Aug;39(4):301–311. doi: 10.1136/ard.39.4.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gerber D. A. Antirheumatic drugs, the ESR, and the hypohistidinemia of rheumatoid arthritis. J Rheumatol. 1977 Spring;4(1):40–45. [PubMed] [Google Scholar]
  4. HAMILTON E. B., SCOTT J. T. Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis. Arthritis Rheum. 1962 Oct;5:502–512. doi: 10.1002/art.1780050507. [DOI] [PubMed] [Google Scholar]
  5. Mackenzie A. H. An appraisal of chloroquine. Arthritis Rheum. 1970 May-Jun;13(3):280–291. doi: 10.1002/art.1780130310. [DOI] [PubMed] [Google Scholar]
  6. Marks J. S., Power B. J. Is chloroquine obsolete in treatment of rheumatic disease? Lancet. 1979 Feb 17;1(8112):371–373. doi: 10.1016/s0140-6736(79)92905-2. [DOI] [PubMed] [Google Scholar]
  7. McConkey B., Crockson R. A., Crockson A. P., Wilkinson A. R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med. 1973 Oct;42(168):785–791. [PubMed] [Google Scholar]
  8. Pickup M. E., Dixon J. S., Bird H. A. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum. J Pharm Pharmacol. 1980 Apr;32(4):301–302. doi: 10.1111/j.2042-7158.1980.tb12920.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES